The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The chlamydia infection diagnostics and therapeutics market has experienced significant growth, rising from $1.35 billion in 2023 to $1.43 billion in 2024, with a compound annual growth rate (CAGR) of 5.6%. This growth is attributed to an increase in sexual activity, improvements in healthcare infrastructure, government initiatives and funding, growing awareness and screening programs, and a rising prevalence of chlamydia infections. The market is expected to continue growing, reaching $1.79 billion by 2028 at a CAGR of 5.9%. This forecast growth is driven by awareness campaigns, high healthcare expenditure, a rising incidence among young adults, regulatory approvals, expanding healthcare infrastructure, and increasing antibiotic resistance. Major trends in the forecast period include advancements in diagnostic technologies, development of point-of-care tests, collaborations and partnerships, creation of effective treatment options, and technological advancements.

The rising incidence of sexually transmitted infections is expected to propel the growth of the chlamydia infection diagnostics and therapeutics market going forward. Sexually transmitted infections (STIs) are spread through sexual contact and are increasing due to factors such as inconsistent barrier use, lack of awareness about safe sex, and decreased public health funding for prevention. Chlamydia infection diagnostics and therapeutics are crucial for managing these infections by ensuring early detection and effective treatment to prevent complications and transmission. For instance, in May 2024, the World Health Organization reported over 1 million curable STIs acquired daily worldwide among individuals aged 15–49 years, with most being asymptomatic. Therefore, the rising incidence of STIs globally is driving the chlamydia infection diagnostics and therapeutics market.

Get A Free Sample On The Chlamydia Infection Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18295&type=smp

What Are The Key Trends That Influence Chlamydia Infection Diagnostics Market Share Analysis?
Major companies operating in the chlamydia infection treatment market focus on developing advanced diagnostic technologies, such as fully automated, high-throughput infectious disease molecular diagnostic platforms, to enhance diagnostic accuracy and streamline laboratory workflows. A fully automated, high-throughput infectious disease molecular diagnostic platform is a cutting-edge system designed to streamline and improve the detection of infectious diseases. For instance, in May 2022, Becton, Dickinson, and Company (BD), a US-based medical company, launched the new BD CORTM MX instrument, a fully automated, high-throughput infectious disease molecular diagnostic platform. This advanced medical device is designed to enhance diagnostic capabilities in clinical laboratories, offering automated molecular testing solutions. The BD CORTM MX/PX System fully automates the entire molecular laboratory workflow, handling everything from sample processing to delivering diagnostic test results. It is designed for high-throughput laboratories. This detects the three most prevalent non-viral sexually transmitted infections (STIs), Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV) in a single test.

How Is The Global Chlamydia Infection Diagnostics Market Segmented?
1) By Type: Nucleic Acid Amplification Tests (NAATS); Direct Fluorescent Tests; Macrolides; Quinolones; Sulfonamides; Tetracycline; Aminopenicillins
2) By Type Of Infections: Genital Chlamydia Infection; Rectal Chlamydia Infection; Ocular Chlamydia Infection
3) By Application: Hospitals; Specialty Clinics; Diagnostic Centers Therapeutics; Hospital Pharmacies; Drugstores; Retail Pharmacies; Online Pharmacies

Read The Full Chlamydia Infection Diagnostics Market Report Here:
https://www.thebusinessresearchcompany.com/report/chlamydia-infection-diagnostics-and-therapeutics-global-market-report

The Chlamydia Infection Diagnostics Global Market Report 2024 provides an overview of the chlamydia infection diagnostics market for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The chlamydia infection diagnostics market forecast analyzes chlamydia infection diagnostics market size, chlamydia infection diagnostics market share, leading competitor and their market positions.

The Table Of Content For The Chlamydia Infection Diagnostics Market Include:

Explore Similar Reports From The Business Research Company:
Chlamydia Infection Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/chlamydia-infection-treatment-global-market-report

Chlamydia Trachomatis (CT) And Neisseria Gonorrhoeae (NG) Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/chlamydia-trachomatis-ct-and-neisseria-gonorrhoeae-ng-testing-global-market-report

STD Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: